Abstract:Dependence and impairment of learning and memory are two well-established features caused by abused drugs such as opioids. The hippocampus is an important region associated with both drug dependence and learning and memory. However, the molecular events in hippocampus following exposure to abused drugs such as opioids are not well understood. Here we examined the effect of chronic morphine treatment on hippocampal protein expression by proteomic analyses. We found that chronic exposure of mice to morphine for 10 days produced robust morphine withdrawal jumping and memory impairment, and also resulted in a significant downregulation of hippocampal protein levels of three metabolic enzymes, including Fe-S protein 1 of NADH dehydrogenase, dihydrolipoamide acetyltransferase or E2 component of the pyruvate dehydrogenase complex and lactate dehydrogenase 2. Further real-time quantitative PCR analyses confirmed that the levels of the corresponding mRNAs were also remarkably reduced. Consistent with these findings, lower ATP levels and an impaired ability to convert glucose into ATP were also observed in the hippocampus of chronically treated mice. Opioid antagonist naltrexone administrated concomitantly with morphine significantly suppressed morphine withdrawal jumping and reversed the downregulation of these proteins. Acute exposure to morphine also produced robust morphine withdrawal jumping and significant memory impairment, but failed to decrease the expression of these three proteins. Intrahippocampal injection of D-glucose before morphine administration significantly enhanced ATP levels and suppressed morphine withdrawal jumping and memory impairment in acute morphine-treated but not in chronic morphine-treated mice. Intraperitoneal injection of high dose of D-glucose shows a similar effect on morphine-induced withdrawal jumping as the central treatment. Taken together, our results suggest that reduced expression of the three metabolic enzymes in the hippocampus as a result of chronic morphine treatment contributes to the development of drug-induced symptoms such as morphine withdrawal jumping and memory impairment.

Morphine Withdrawal Increases Glutamate Uptake and Surface Expression of Glutamate Transporter GLT1 at Hippocampal Synapses

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Opiate Withdrawal Induces Dynamic Expressions of AMPA Receptors and Its Regulatory Molecule CaMKIIα in Hippocampal Synapses

Morphine modulates glutamate release in the hippocampal CA1 area in mice.

Potentiation of Synaptic Strength and Intrinsic Excitability in the Nucleus Accumbens after 10 Days of Morphine Withdrawal.

Mu-Opioid Receptors Expressed in Glutamatergic Neurons Are Essential for Morphine Withdrawal.

Increased Glutamate Synaptic Transmission in the Nucleus Raphe Magnus Neurons from Morphine-Tolerant Rats

Downregulation of mGluR2/3 receptors during morphine withdrawal in rats impairs mGluR2/3- and NMDA receptor-dependent long-term depression in the nucleus accumbens.

Enhanced Ability of TRPV1 Channels in Regulating Glutamatergic Transmission after Repeated Morphine Exposure in the Nucleus Accumbens of Rat

Downregulation of Mglur2/3 Receptors During Morphine Withdrawal in Rats Impairs Mglur2/3- and NMDA Receptor-Dependent Long-Term Depression in the Nucleus Accumbens

Effects and mechanisms of chronic morphine exposure on extracellular glutamate concentration in C6 cells

Chronic exposure to morphine decreases the expression of EAAT3 via opioid receptors in hippocampal neurons.

Ionotropic Glutamatergic Neurotransmission in the Ventral Tegmental Area Modulates ΔFosB Expression in the Nucleus Accumbens and Abstinence Syndrome in Morphine Withdrawal Rats

Expression Changes of Hippocampal Energy Metabolism Enzymes Contribute to Behavioural Abnormalities During Chronic Morphine Treatment

Opiate withdrawal modifies synaptic plasticity in subicular-nucleus accumbens pathway in vivo.

Region-specific alterations in glutamate receptor 1 phosphorylation during context-induced drug seeking after withdrawal from morphine self-administration.

Region-specific Alterations in Glutamate Receptor 1 Phosphorylation During Context-Induced Drug Seeking after Withdrawal from Morphine Self-Administration

Mesoaccumbens Dopamine Signaling Alteration Underlies Behavioral Transition from Tolerance to Sensitization to Morphine Rewarding Properties During Morphine Withdrawal

Acute and chronic morphine treatments and morphine withdrawal differentially regulate GRK2 and GRK5 gene expression in rat brain.

Morphine treatment enhances glutamatergic input onto neurons of the nucleus accumbens via both disinhibitory and stimulating effect.